GCLC and colorectal carcinoma: Moreover, lipid ROS, cell death, and ferroptosis sensitivity were partially reversed under GCLC retrieved (Fig. 5Q-R, S6T–U, X-Y), indicating that SNORA56 contributes to ferroptosis resistance in CRC mediated by GCLC.